Skip to content
HOME
ABOUT US
What is JLM-BioCity?
What We Do
Board of Advisors
Meet the Team
EVENTS
Past Events
Event Clips
RESOURCES
JLM Bio Innovation
JLM Companies
JLM Landscape
BioTips
Blog
Briefs
JOIN US
Our Partners
Become a Partner
CONTACT US
Search for:
Menu
Close
HOME
ABOUT US
What is JLM-BioCity?
What We Do
Board of Advisors
Meet the Team
EVENTS
Past Events
Event Clips
RESOURCES
JLM Bio Innovation
JLM Companies
JLM Landscape
BioTips
Blog
Briefs
JOIN US
Our Partners
Become a Partner
CONTACT US
20221130 Nectin Therapeutics banner
Home
>
With Added $25M+ Financing, Nectin Therapeutics Initiates Patient Dosing in Advanced Solid Tumors NTX1088 Phase 1 Trial
>
20221130 Nectin Therapeutics banner